药物信息为EPOPROSTENOL (GeneraMedix Inc ): INDICATIONS AND USAGE
- INDICATIONS AND USAGE
- DOSAGE AND ADMINISTRATION
- DOSAGE FORMS AND STRENGTHS
- DRUG INTERACTIONS
- PATIENT COUNSELING INFORMATION
- Diseases/Conditions Related to EPOPROSTENOL (GeneraMedix Inc )
- 外部链接相关的EPOPROSTENOL (GeneraMedix Inc )
Epoprostenol is indicated for:
- the long-term intravenous treatment of primary pulmonary hypertension
- and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy
- [see CLINICAL STUDIES: Clinical Trials in Pulmonary Hypertension (14.1) ].
- Drug Information Provided by National Library of Medicine (NLM).